8/28/2023 0 Comments Vice media group logoDamouni Ellis joins Vir from Marinus Pharmaceuticals, where she served as Senior Vice President, Corporate Affairs and Investor Relations. “I look forward to working with Marianne and the exceptional team and Board of Directors at Vir who have established a successful track record of scientific innovation, commitment to patients and a strong employee culture.” “I’m honored to join Vir, a company with a strong clinical pipeline and an exciting future ahead targeting significant unmet medical needs around the world,” said Ms. Her insights and expertise will be invaluable to our executive team as we continue advancing our robust pipeline of innovative therapies aimed at the treatment of infectious diseases,” said Dr. “Sasha has an impressive track record as both a corporate communications and investor relations leader. She will report to Vir’s Chief Executive Officer Marianne De Backer, M.Sc., Ph.D., MBA, and will join the Company’s Executive Management Team. Damouni Ellis will be responsible for the Company’s strategic approach to corporate communications, government affairs, investor relations and patient advocacy, as well as for establishing Vir’s corporate social responsibility and environmental, social and governance efforts. (Nasdaq: VIR) today announced the appointment of Sasha Damouni Ellis as Executive Vice President and Chief Corporate Affairs Officer, effective July 10, 2023. SAN FRANCISCO, J(GLOBE NEWSWIRE) - Vir Biotechnology, Inc.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |